Physician profile
Peter D Berman
NPI 1427064302
$4,029.94
in general payments reported to CMS, 2019-2025
28 companies · $595 in 2025
The $595 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $437 · 2020: $196 · 2021: $208 · 2022: $216 · 2023: $1,050 · 2024: $1,328 · 2025: $595.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,915 · Education: $57.82.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,915.39 |
| Education | $57.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurent Medical Limited | $1,196.42 | 2023-2025 | Neuromark Radiofrequency Console, Neuromark Device, Neuromark System |
| Glaxosmithkline, LLC. | $509.67 | 2019-2025 | Nucala |
| Genzyme Corporation | $298.96 | 2021-2024 | |
| Kaleo, INC. | $225.44 | 2019-2024 | Auvi-Q |
| Optinose US, INC. | $217.92 | 2022-2025 | |
| Regeneron Healthcare Solutions, INC. | $201.81 | 2023-2025 | Dupixent |
| Stryker Corporation | $182.82 | 2019 | |
| Genentech USA, INC. | $165.55 | 2024-2025 | Xolair |
| Inspire Medical Systems, INC. | $150.10 | 2023 | Inspire |
| Medtronic, INC. | $140.53 | 2024-2025 | Stealthstation S8 Platform, Propel, Nuvent |
| Leo Pharma INC. | $85.65 | 2022-2023 | Adbry |
| Aerin Medical INC. | $77.24 | 2019 | |
| Novartis Pharmaceuticals Corporation | $69.44 | 2019-2023 | |
| Teva Pharmaceuticals USA, INC. | $61.97 | 2020 | |
| Intersect Ent, INC. | $60.00 | 2021 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alk-Abello, INC | $51.44 | 2019-2022 | |
| Acclarent, INC | $44.89 | 2022 | |
| Incyte Corporation | $43.41 | 2021-2024 | Opzelura |
| Medtronic USA, INC. | $39.53 | 2019-2020 | |
| Integra Lifesciences Corporation | $38.70 | 2025 | Trudi Probe, Relieva Spinplus Nav, Inspira Air |
| Amgen INC. | $34.30 | 2024 | Tezspire |
| Abbvie INC. | $30.99 | 2024 | |
| Biocryst US Sales Co., LLC | $21.44 | 2025 | Orladeyo |
| Astrazeneca Pharmaceuticals LP | $21.11 | 2023 | Tezspire |
| Hikma Pharmaceuticals USA | $17.06 | 2025 | Ryaltris |
| Phadia US INC. | $16.90 | 2023 | Immunocap |
| Glenmark Therapeutics INC. | $14.00 | 2019 | |
| Eyevance Pharmaceuticals LLC | $12.65 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Berman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.